Cargando…
Hydroxyurea-induced cutaneous squamous cell carcinoma: A case report
BACKGROUND: Hydroxyurea (HU) is a non-alkylating antineoplastic agent that is active in the S-phase of the cell cycle and inhibits the enzyme ribonucleoside reductase. HU is currently used to treat leukemia, sickle cell anemia, psoriasis, and chronic myeloproliferative disorders. Although HU is easy...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906572/ https://www.ncbi.nlm.nih.gov/pubmed/31832413 http://dx.doi.org/10.12998/wjcc.v7.i23.4091 |